ICON PUBLIC LIMITED COMPANY Funds and ETFs ICON Public Limited Company
Equities
ICLR
IE0005711209
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 308.3 USD | +2.74% |
|
+6.97% | +8.92% |
| Apr. 26 | UBS Adjusts ICON Price Target to $380 From $368, Maintains Buy Rating | MT |
| Apr. 25 | Transcript : ICON Public Limited Company, Q1 2024 Earnings Call, Apr 25, 2024 |
ETFs positioned on ICON Public Limited Company
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.68% | 2 M€ | -.--% | ||
| 1.28% | 7 M€ | -.--% | - | |
| 0.91% | 5 M€ | +8.63% | ||
| 0.12% | 205 M€ | -.--% | ||
| 0.12% | 7 M€ | +1.95% | - | |
| 0.03% | 0 M€ | 0.00% | - | |
| 0.02% | 389 M€ | +6.83% | - | |
| 0.02% | 34 M€ | +6.71% | - | |
| 0.02% | 302 M€ | +3.80% | - | |
| 0.02% | 39 M€ | +3.67% | - | |
| 0.01% | 17 M€ | +1.44% | - | |
| 0.01% | 6 M€ | +3.89% | ||
| 0.01% | 108 M€ | +2.03% | - | |
| 0.01% | 8 M€ | -0.60% | - | |
| 0.01% | 52 M€ | -0.60% | - | |
| 0.00% | 34 M€ | +2.14% | - |
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Calendar
2024-07-23
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
308.3
USD
Average target price
354.1
USD
Spread / Average Target
+14.87%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +8.92% | 25.49B | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B | |
| -16.98% | 10.07B |
- Stock Market
- Equities
- ICLR Stock
- Funds and ETFs ICON Public Limited Company
